Up-regulated miR155 Reverses the Epithelial-mesenchymal Transition Induced by EGF and Increases Chemo-sensitivity to Cisplatin in Human Caski Cervical Cancer Cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
K Polyak, 2009, Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits, Nat Rev Cancer, 9265
JP Thiery, 2009, Epithelial-mesenchymal transitions in development and disease, Cell, 139, 871
ML Ackland, 2003, Epidermal growth factor-induced epithelial-mesenchymal transition in human breast carcinoma cells, Lab Invest, 83, 435
MR Shen, 2006, Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling, Carcinogenesis, 27, 962
T Hagemann, 2007, Molecular profiling of cervical cancer progression, Br J Cancer, 96, 321
M Moes, 2012, A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition, PLoS One, 7, e35440
Xia H, Hui KM (2012) MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics, Cancer Gene Ther. doi: 10.1038.
JK Ryu, 2010, Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma, Pancreatology, 10, 66
T Greither, 2010, Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival, Int J Cancer, 126, 73
MÁ Castilla, 2011, Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma, J Pathol, 223, 72
Songtao Qi, Ye Song, Yuping Peng, Hao Wang, Hao Long (2012) ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma, PLoS One. 7: e 38842.
QQ Li, 2009, Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells, Clin Cancer Res, 15, 2657
MY Lee, 2008, Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation, Clin Cancer, Res, 4743
K Iida, 2011, EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target, Br J Cancer, 105, 420
R Narayanan, 2012, Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels. Int J Oncol, 40, 13
CP Bracken, 2008, A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res, 68, 7846
A Ahmad, 2011, Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells, Cancer Research, 71, 3400
NH Kim, 2011, A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition, J Cell Biol, 195, 417, 10.1083/jcb.201103097
Y Ono, 2012, Direct inhibition of the transforming growth factor-β pathway by protein-bound polysaccharide through inactivation of Smad2 signaling, Cancer Sci, 103, 317
X Xiang, 2011, miR155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT, Oncogene, 30, 3440
M Gironella, 2007, Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development, Proc Natl Acad Sci USA, 104, 16170
S Jiang, 2010, MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene, Cancer Res, 70, 3119
W Kong, 2008, MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA, Mol Cell Biol, 28, 6773
NP Tobin, 2011, Cyclin D1, Id1 and EMT in breast cancer, BMC Cancer, 11, 417
L Zheng, 2011, Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer, PLoS One, 6, e19390